References
- McKetin R, Kozel N, Douglas J, et al. The rise of methamphetamine in Southeast and East Asia. Drug Alcohol Rev 2008; 27: 220–228
- Griffiths P, Mravcik V, Lopez D, Klempova D. Quite a lot of smoke but very limited fire—the use of methamphetamine in Europe. Drug Alcohol Rev 2008; 27: 236–242
- Degenhardt A, Roxburgh A, Black E, et al. The epidemiology of methamphetamine use and harm in Australia. Drug Alcohol Rev 2008; 27: 243–252
- Maxwell J C, Rutkowski B A. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992 – 2007. Drug Alcohol Rev 2008; 27: 229–235
- Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 2008; 27: 253–262
- Sherman S G, German D, Sirirojn B, Thompson N, Aramrattana A, Celentano D D. A qualitative study of sexual behaviours among methamphetamine users in Chiang Mai, Thailand: a typology of risk. Drug Alcohol Rev 2008; 27: 263–269
- Wood E, Stoltz J-A, Zhang R, Strathdee S A, Montaner J SG, Kerr T. Circumstances of first crystal methamphetamine use and initiation of injection drug use among high-risk youth. Drug Alcohol Rev 2008; 27: 270–276
- Inglez-Dias A, Hahn J A, Lum P J, Evans J, Davidson P, Page-Shafer K. Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO study. Drug Alcohol Rev 2008; 27: 286–291
- McKetin R, Ross J, Kelly E, et al. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug Alcohol Rev 2008; 27: 277–285
- Kinner S, Degenhardt L. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm. Drug Alcohol Rev 2008; 27: 292–300
- Lee N K, Rawson R A. A systematic review of cognitive and/or behavioural therapies for methamphetamine dependence. Drug Alcohol Rev 2008; 27: 309–317
- Kaye-Lambkin F J. Technology and innovation in the psychosocial treatment of methamphetamine use, risk and dependence. Drug Alcohol Rev 2008; 27: 318–325
- Roche A M, Pidd K, Bywood P, Freeman T. Methamphetamine use among Australian workers and its implications for prevention. Drug Alcohol Rev 2008; 27: 334–341
- Shearer J. The principles of agonist pharmacotherapy for psychostimulant dependence. Drug Alcohol Rev 2008; 27: 301–308
- Cruickshank C C, Montebello M E, Dyer K R, et al. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal. Drug Alcohol Rev 2008; 27: 326–338